Delray Beach, Florida, December 6, 2022—Last Writes, LLC, in collaboration with BookLocker.com, Inc., announces the release of The Scenturion Spy, Book One, of a series by Dr. David M. Goldenberg, founder and former Chairman and Chief Scientific Officer of Immunomedics, Inc.
Dr. Goldenberg and his team developed Trodelvy®, now approved in the U.S. and other countries for the treatment of advanced, refractive, triple-negative breast and urothelial cancers, and being studied in several other solid cancers. Dr. Goldenberg also was founder and President of the Garden State Cancer Center in New Jersey, supported by grants from the National Cancer Institute. He is a graduate of the University of Chicago (S.B.), the University of Erlangen-Nuremberg (Sc.D.), and the University of Heidelberg (M.D., magna cum laude).
The Scenturion Spy details the research and espionage activities of Milt Davidson, M.D., Ph.D., the science based on the author’s own research experience. The story’s protagonist is an academic physician-scientist at a prominent New York medical school. Because the sense of smell is the least studied and understood of our five senses, this novel introduces a potentially new drug therapy involving smelling defined odors, as well as insight into an international competition on the use of scents in bioweaponry.
This leads the CIA to engage and train Dr. Davidson to spy on Russia’s efforts to develop an olfaction bioweaponry. Establishing a biotechnology firm in Moscow, supported by multinational investors, including a Russian oligarch, Dr. Davidson has an ideal cover.
James W. Freeman, Ph.D., author of “The Boys of Laurel” and an experimental pathologist, commented: “In his debut novel, David M. Goldenberg hits it out of the park with The Scenturion Spy… (It) is a captivating debut filled with intriguing characters. The storyline, set in the modern day, has all the attributes of a great spy novel, and leaves you asking for the sequel.”
Azra Raza, M.D., author of “The First Cell: And the Human Costs of Pursuing Cancer to the Last,” Chan Soon-Shiong Professor of Medicine at Columbia University Medical Center, said: “I loved it; he tells the story beautifully, with amazing details. The science, the startup issues, the departmental politics, the wrenching anguish, and dilemmas of entering the spy world while wanting to continue his fantastic research…all described faithfully while keeping the interest of the reader engaged. I greatly enjoyed it, and finished it in two sittings.”
The Scenturion Spy is available at Amazon in paperback, and soon in hard cover and eBook.